EUROFINS SCIENT. (ERF.PA) Financials
ERF.PA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.9 billion | 6.8 billion |
| 2023-06-30 | 10.3 billion | 5.3 billion |
| 2023-03-31 | 10.3 billion | 5.3 billion |
| 2022-12-31 | 10.1 billion | 5.2 billion |
ERF.PA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 340.0 million | ? |
| 2023-06-30 | 57.2 million | 30.1 million |
| 2023-03-31 | 52.6 million | 30.1 million |
| 2022-12-31 | 119.0 million | 34.0 million |
ERF.PA Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 158.8 million |
| 2023-06-30 | 151.5 million |
| 2023-03-31 | 75.8 million |
| 2022-12-31 | 195.0 million |
ERF.PA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 1.2 billion | - | 578.8 million |
| 2023-06-30 | 686.4 million | 3.1 billion | 538.2 million |
| 2023-03-31 | 686.4 million | - | - |
| 2022-12-31 | 486.6 million | 3.1 billion | 527.6 million |
ERF.PA Shares Outstanding
ERF.PA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 287.4 million | - | - | - |
| 2023-06-30 | 262.7 million | - | - | - |
| 2023-03-31 | 114.0 million | - | - | - |
| 2022-12-31 | 165.1 million | - | - | - |
ERF.PA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.3 billion | 3.0 billion |
| 2023-06-30 | 3.2 billion | 2.9 billion |
| 2023-03-31 | 1.6 billion | 1.3 billion |
| 2022-12-31 | 3.3 billion | 3.0 billion |
ERF.PA
Price: €58.26
Dividend Yield: 0.01%
Forward Dividend Yield: 1.72%
Payout Ratio: 62.89%
Dividend Per Share: 1.00 EUR
Earnings Per Share: 1.57 EUR
P/E Ratio: 24.33
Exchange: PAR
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 11.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 3